COMT Val158Met Genotype Selectively Alters Prefrontal [18F]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hernaus, Dennis ^a   Collip, Dina ^a   Lataster, Johan ^a,b   Ceccarini, Jenny ^c   Kenis, Gunther ^a   Booij, Linda ^d,e,f   Pruessner, Jens ^g   van Laere, Koen ^c   van Winkel, Ruud ^a,h   van Os, Jim ^a,i   Myin Germeys, Inez ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; FALLYPRIDE F 18; FLUORINE 18; METHIONINE; TRACER; UNCLASSIFIED DRUG; VALINE; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; N ((1 ALLYL 2 PYRROLIDINYL)METHYL) 5 (3 FLUOROPROPYL) 2,3 DIMETHOXYBENZAMIDE; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; ELECTROENCEPHALOGRAM; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; INFERIOR FRONTAL GYRUS; MALE; MENTAL DISEASE; MENTAL STRESS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHOSIS; SUPERIOR FRONTAL GYRUS; AMINO ACID SUBSTITUTION; ENZYMOLOGY; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SCINTISCANNING; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; YOUNG ADULT; DIAGNOSTIC USE; PSYCHOLOGY;

ADULT; AMINO ACID SUBSTITUTION; BENZAMIDES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; PYRROLIDINES; RADIOPHARMACEUTICALS; STRESS, PSYCHOLOGICAL; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84879064248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065662     Document Type: Article

References (57)

1. Mannisto PT, Kaakkola S, (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological reviews 51: 593-628.
2. Tunbridge EM, Harrison PJ, Weinberger DR, (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological psychiatry 60: 141-151.
3. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America 100: 6186-6191.
4. Slifstein M, Kolachana B, Simpson EH, Tabares P, Cheng B, et al. (2008) COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Molecular psychiatry 13: 821-827.
5. Mier D, Kirsch P, Meyer-Lindenberg A, (2010) Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Molecular psychiatry 15: 918-927.
6. Stein DJ, Newman TK, Savitz J, Ramesar R, (2006) Warriors versus worriers: the role of COMT gene variants. CNS spectrums 11: 745-748.
7. Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, et al. (2008) Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. The Journal of neuroscience: the official journal of the Society for Neuroscience 28: 8709-8723.
8. Collip D, van Winkel R, Peerbooms O, Lataster T, Thewissen V, et al. (2011) COMT Val158Met-stress interaction in psychosis: role of background psychosis risk. CNS neuroscience & therapeutics 17: 612-619.
9. Walder DJ, Trotman HD, Cubells JF, Brasfield J, Tang YL, et al. (2010) Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents. Psychiatric genetics 20: 166-170.
10. van Winkel R, Henquet C, Rosa A, Papiol S, Fananas L, et al. (2008) Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics 147B: 10-17.
11. Lataster J, Collip D, Ceccarini J, Haas D, Booij L, et al. (2011) Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [(1)F]fallypride. NeuroImage 58: 1081-1089.
12. Pruessner JC, Champagne F, Meaney MJ, Dagher A, (2004) Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. The Journal of neuroscience: the official journal of the Society for Neuroscience 24: 2825-2831.
13. van Winkel R, Stefanis NC, Myin-Germeys I, (2008) Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophrenia bulletin 34: 1095-1105.
14. Tunbridge E, Burnet PW, Sodhi MS, Harrison PJ, (2004) Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 51: 112-118.
15. Hirvonen MM, Nagren K, Rinne JO, Pesonen U, Vahlberg T, et al. (2010) COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging 12: 192-197.
16. Davis KL, Kahn RS, Ko G, Davidson M, (1991) Dopamine in schizophrenia: a review and reconceptualization. The American journal of psychiatry 148: 1474-1486.
17. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 98: 6917-6922.
18. Lataster T, Wichers M, Jacobs N, Mengelers R, Derom C, et al. (2009) Does reactivity to stress cosegregate with subclinical psychosis? A general population twin study. Acta psychiatrica Scandinavica 119: 45-53.
19. Myin-Germeys I, Delespaul P, van Os J, (2005) Behavioural sensitization to daily life stress in psychosis. Psychological medicine 35: 733-741.
20. Woodward ND, Cowan RL, Park S, Ansari MS, Baldwin RM, et al. (2011) Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. The American journal of psychiatry 168: 418-426.
21. Lataster J, Collip D, Ceccarini J, Hernaus D, Haas D, et al. (2013) Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex. Schizophrenia bulletin.
22. Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, et al. (2002) Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46: 170-188.
23. Alpert NM, Badgaiyan RD, Livni E, Fischman AJ, (2003) A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. NeuroImage 19: 1049-1060.
24. Badgaiyan RD, Wack D, (2011) Evidence of dopaminergic processing of executive inhibition. PloS one 6: e28075.
25. Christian BT, Lehrer DS, Shi B, Narayanan TK, Strohmeyer PS, et al. (2006) Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task. NeuroImage 31: 139-152.
26. Ceccarini J, Vrieze E, Koole M, Muylle T, Bormans G, et al. (2012) Optimized in vivo detection of dopamine release using 18F-fallypride PET. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 53: 1565-1572.
27. Backman L, Nyberg L, Soveri A, Johansson J, Andersson M, et al. (2011) Effects of working-memory training on striatal dopamine release. Science 333: 718.
28. McGuffin P, Farmer A, Harvey I, (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of general psychiatry 48: 764-770.
29. Vrieze E, Ceccarini J, Pizzagalli DA, Bormans G, Vandenbulcke M, et al. (2011) Measuring extrastriatal dopamine release during a reward learning task. Human brain mapping.
30. Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, et al. (1996) Comparison of methods for analysis of clinical [11C]raclopride studies. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 16: 42-52.
31. Vernaleken I, Peters L, Raptis M, Lin R, Buchholz HG, et al. (2011) The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 31: 1958-1966.
32. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, et al. (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 27: 1533-1539.
33. StataCorp (2009) STATA/SE statistical software, release 11. Texas: College Station.
34. Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, et al. (2011) Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 6692-6698.
35. Buckert M, Kudielka BM, Reuter M, Fiebach CJ (2012) The COMT Val158Met polymorphism modulates working memory performance under acute stress. Psychoneuroendocrinology.
36. Scornaiencki R, Cantrup R, Rushlow WJ, Rajakumar N, (2009) Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 12: 1195-1208.
37. Deutch AY, Clark WA, Roth RH, (1990) Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain research 521: 311-315.
38. Jabbi M, Korf J, Kema IP, Hartman C, van der Pompe G, et al. (2007) Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Molecular psychiatry 12: 483-490.
39. Stokes PR, Egerton A, Watson B, Reid A, Breen G, et al. (2010) Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. NeuroImage 52: 1521-1527.
40. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, et al. (2005) Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. The Journal of neuroscience: the official journal of the Society for Neuroscience 25: 836-842.
41. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, et al. (2007) Gene-gene interaction associated with neural reward sensitivity. Proceedings of the National Academy of Sciences of the United States of America 104: 8125-8130.
42. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, et al. (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. The American journal of psychiatry 155: 761-767.
43. Howes OD, Kapur S, (2009) The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia bulletin 35: 549-562.
44. Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, et al. (2012) Increased stress-induced dopamine release in psychosis. Biological psychiatry 71: 561-567.
45. Arnsten AF, Goldman-Rakic PS, (1998) Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Archives of general psychiatry 55: 362-368.
46. Castner SA, Goldman-Rakic PS, (2004) Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. The Journal of neuroscience: the official journal of the Society for Neuroscience 24: 1446-1450.
47. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, et al. (2006) Impact of complex genetic variation in COMT on human brain function. Molecular psychiatry 11: 867-877, 797.
48. Servan-Schreiber D, Printz H, Cohen JD, (1990) A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior. Science 249: 892-895.
49. Peerbooms O, Rutten BP, Collip D, Lardinois M, Lataster T, et al. (2012) Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. Acta psychiatrica Scandinavica 125: 247-256.
50. Karlsson S, Nyberg L, Karlsson P, Fischer H, Thilers P, et al. (2009) Modulation of striatal dopamine D1 binding by cognitive processing. NeuroImage 48: 398-404.
51. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, et al. (1998) Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. The American journal of psychiatry 155: 344-349.
52. Backman L, Ginovart N, Dixon RA, Wahlin TB, Wahlin A, et al. (2000) Age-related cognitive deficits mediated by changes in the striatal dopamine system. The American journal of psychiatry 157: 635-637.
53. Riccardi P, Li R, Ansari MS, Zald D, Park S, et al. (2006) Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 31: 1016-1026.
54. Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, et al. (2010) Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse 64: 350-362.
55. Lammertsma AA, Hume SP, (1996) Simplified reference tissue model for PET receptor studies. NeuroImage 4: 153-158.
56. Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, et al. (2008) Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse 62: 399-408.
57. Yoder KK, Wang C, Morris ED, (2004) Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 45: 903-911.